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Abstract
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Purpose—Little is known about gender differences in the treatment of pain after motor vehicle
collisions (MVCs) in the emergency department (ED). We aimed to describe gender differences in
pain experiences and treatment, specifically the use of opioids and benzodiazepines after ED
discharge, for MVC-related pain.
Methods—This was a secondary analysis of previously collected data from the CRASH studies.
We included patients who were seen and discharged from the Emergency Department (ED) after a
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MVC and who were enrolled in one of two multicenter longitudinal prospective cohort studies
(one Black/Non-Hispanic and one White/Non-Hispanic). First, we compared the experience of
pain as defined by self-reported moderate to severe axial pain, widespread pain, number of somatic
symptoms, pain catastrophizing, and peritraumatic distress between women and men using
bivariate analyses. We then determined if there were gender differences in the receipt of
prescription medications for post-MVC pain symptoms (opioids and benzodiazepines) using
mutlivariate logistic regression adjusting for demographics, pain, and collision characteristics.

Author Manuscript

Findings—In total, 1878 patients were included: 61.4% were women. More women reported
severe symptoms on the pain catastrophizing scale (36.8% vs. 31.0%, p=0.032) and peritraumatic
distress following the MVC (59.7% vs. 42.5%, p<0.001), and women reported more somatic
symptoms than men (median 3.9, IQR 3.7–4.0 vs. 3.3, IQR 3.1–3.5, p<0.001). Unadjusted, similar
proportions of women and men were given opioids (29.2% vs. 29.7%, p=0.84). After adjusting for
covariates, women and men remained equally likely to receive a prescription for opioids (RR 0.83,
95%CI 0.58–1.19). Women, however, were less likely than men to receive a benzodiazepine at
discharge (RR 0.53, 95%CI 0.32–0.88).
Implications—In a large, multicenter study of ED patients treated for MVC, there were gender
differences in the acute psychological response to MVC with women reporting more
psychological and somatic symptoms. Women and men were equally likely to receive opioid
prescriptions at discharge. Future research should investigate potential gender-specific
interventions to reduce both post-traumatic distress and the risk of developing negative long-term
outcomes like chronic pain.
Keywords
gender; pain; opioids; gender differences
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INTRODUCTION
Injuries related to motor vehicle collisions (MVCs) account for over 4 million emergency
department (ED) visits every year.1 Post-traumatic musculoskeletal pain resulting from
MVCs has potential negative outcomes including persistent pain (pain that lasts beyond the
expected normal recovery time)2 and even chronic widespread pain,3 a condition associated
with decreased physical independence as well as a lower quality of life.4

Author Manuscript

Based on literature supporting gender differences in a range of painful conditions such as
headache, chronic pain syndromes, and musculoskeletal pain,5 gender differences in posttraumatic pain may also exist.6, 7 Differences in pain between women and men across
conditions are extensive and include differences in the severity and intensity of reported
pain, pain sensitivity, prevalence of chronic pain, pain-associated distress and anxiety, and
pain-induced hyperalgesia. 5, 6, 8–10 In addition, previous data have shown gender
differences in both the receipt of analgesic treatment in the emergency department and in the
response to treatment that is given (e.g., opioids). 5, 11–1314, 15 Potential gender differences
in pain perception, experience, treatment, and outcomes after MVCs could have important
implications on the development of chronic pain and related outcomes following a traumatic
event.
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Post-traumatic pain is often treated with opioids after ED discharge,16 and musculoskeletal
pain (including that resulting from trauma) treated in the ED or primary care setting is often
treated with opioids and/or benzodiazepines.17, 18 Some data also suggest that there are
increased rates of benzodiazepine use among patients in the months following a MVC.19
Given the large number of opioids being prescribed in the U.S.20 and the high prevalence of
substance use disorders related to prescription opioid and benzodiazepines,20 it is especially
important to understand whether there are gender differences in the treatment response,
outcomes of post-traumatic pain including persistent or chronic pain, or in effects of opioid
and/or benzodiazepine use among those treated for pain from MVCs. Though not specific to
post-traumatic pain, data do show that prescriptions for benzodiazepines, which have the
potential for abuse and long-term withdrawal, are approximately twice as common in
women than men across all clinical indications.21

Author Manuscript

Before we can adequately explore gender differences in the long-term outcomes of posttraumatic pain and the response of post-traumatic pain to opioids and other classes of
medications, we must first better characterize gender differences in acute post-traumatic pain
and its treatment.
Objectives

Author Manuscript

We aimed to describe gender differences in pain and in the prescription of opioids and
benzodiazepines following a MVC. First, we described gender differences in pain
experiences among patients presenting to the ED with isolated musculoskeletal pain after a
MVC. Next, we compared crude rates of opioid and benzodiazepine prescriptions after
MVC between women and men. Finally, we evaluated whether patient gender was
associated with differential prescribing, specifically receipt of an opioid or benzodiazepine
at discharge, after adjusting for pain, demographics, and collision characteristics.

PATIENTS AND METHODS
Study Population/Setting

Author Manuscript

The CRASH project is a prospective, multicenter, observational cohort study funded by the
NIH to study predictors of acute and chronic musculoskeletal pain following minor MVCs.
22 This is a secondary analysis of previously collected data from two cohorts of the CRASH
study, one of white/non-Hispanic patients (the European American (EA) cohort) and one of
Black/non-Hispanic patients (the African-American (AA) cohort), both previously enrolled
in one of two longitudinal prospective studies of patients seen and discharged from the ED
after a MVC. Details of the original study methods have been previously published. 2, 22, 23
In brief, participants were screened and enrolled by trained research assistants. Screening
occurred during day and evening hours based on availability of research assistants and
occurred for approximately 12 to 16 hours each day at each site.22, 23 Data were collected by
trained research assistants during the ED visit using patient interview; additional data were
collected from the medical record following the completion of the ED visit.
For the EA cohort, patients 18 to 65 years old presenting to one of 8 participating EDs
across 4 states (Florida, Massachusetts, Michigan, and New York) within 24 hours of a
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MVC from February 2009 to October 2011 were eligible for enrollment. For the AA cohort,
patients 18 to 65 years old presenting to one of 13 participating EDs across 7 states
(Alabama, Florida, Michigan, Pennsylvania, Washington, D.C., Massachusetts, New Jersey)
within 24 hours of a MVC from 2012 to 2016 were eligible for enrollment. In both cohorts,
patients were excluded if they were admitted to the hospital, had fractures with the exception
of phalanx fractures, had four or more lacerations requiring sutures or one laceration greater
than 20 centimeters long, or had intracranial or spinal injuries. If patients were not alert and
oriented, were pregnant, were inmates, or were not fluent in English, they were also
excluded. Finally, patients were excluded if they were currently taking at least 20 mg of
oxycodone or an equivalent dose of another opioid. The study was IRB approved at each site
and informed consent was obtained from all enrolled patients. The research was conducted
in accordance with the Code of Ethics of the World Medical Association (Declaration of
Helsinki).

Author Manuscript

The initial EA cohort study was powered to assess genetic predictors of acute and chronic
musculoskeletal pain following a MVC with a planned enrollment of 936 participants;22
enrollment for the subsequent AA cohort study was powered based on the EA cohort.23
Outcomes/Definitions

Author Manuscript

Our first outcome was pain experience by gender. Data on several measures of pain
experience were collected: pain intensity (numerical pain scores), presence of widespread
pain (axial pain plus pain in an upper and lower segment plus pain on the left- and rightside), presence of moderate to severe axial pain (pain in the neck, back or shoulders rated as
4 or greater on a 10 point numerical rating scale), number of somatic symptoms (of 10
common post-traumatic symptoms, number of symptoms whose severity was rated equal to
or greater than 1 on a 10-point numerical rating scale), score on the pain catastrophizing
scale24, 25 (a 13- item scale that assesses fear, anxiety, and helplessness in response to pain),
peritraumatic distress (score of 23 or greater on the Peritraumatic Distress Inventory26, 27),
and attitude regarding likelihood of recovery (measured by an item on the Life Orientation
Test-Revised survey28 asking participants how sure they are that they will fully recover from
the accident). Survey instruments for pain catastrophizing,24 peritraumatic distress,27 and
attitude regarding likelihood of recovery28 have each been previously validated.”
Widespread pain, moderate to severe axial pain, number of somatic symptoms, score on the
Pain Catastrophizing Scale, peritraumatic distress, and likelihood of recovery were measured
during the initial ED visit following the MVC.

Author Manuscript

Our next outcome measure, treatment of pain, was operationalized using data on
prescriptions for opioid or benzodiazepines medications given to the participant at time of
discharge from the ED. Medications categorized as opioid agonists included oxycodone,
hydrocodone, or combination medications including oxycodone or hydrocodone. These two
medications comprise > 95% of all opioid prescriptions in our database, and lesser
prescribed opioids were excluded from this analysis (e.g., tramadol, codeine,
hydromorphone). Medications categorized as benzodiazepines included diazepam,
lorazepam, alprazolam, and clonazepam.
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First, baseline descriptive data on demographics (age, race, marital status, body mass index
(BMI), smoking status, highest level of education completed, annual income, employment
status) and collision characteristics (extent of vehicle damage during MVC, driver vs.
passenger, speed of collision, and seat belt use) were reported by gender. Unless otherwise
specified, all analyses were conducted in the combined EA and AA cohorts.

Author Manuscript

Next, to compare pain experience by gender, we used bivariate analyses to compare each
measure of pain experience. Report of widespread pain, moderate to severe axial pain, pain
catastrophizing score, attitude toward likelihood of recovery, and peritraumatic distress were
compared between women and men using chi-square tests. Number of somatic symptoms
were compared by gender using students’ t-tests. In additional analyses, we stratified the
entire sample by cohort (EA and AA) and then reported outcomes by gender. Within each
race cohort, women and men were compared with regard to pain experiences (widespread
pain, moderate to severe axial pain, number of somatic symptoms, severe symptoms on the
pain catastrophizing scale, peritraumatic distress, and attitude towards likelihood of
recovery).
To analyze receipt of opioids or benzodiazepines at time of ED discharge, we first conducted
unadjusted analyses comparing the proportion of women versus men who received
prescriptions for: 1) opioids and 2) benzodiazepines at the time of discharge from the ED
using chi-square tests. These gender-based comparisons were compared in the overall
sample and then in the sample stratified by cohort (EA and AA).

Author Manuscript
Author Manuscript

To assess whether confounders affected the treatment of pain in women vs. men, we
performed multivariate logistic regression, using receipt of an opioid prescription as the
outcome and gender as the primary predictor variable. Based on scientific plausibility of
factors associated with opioid use for pain after MVC, the model was adjusted a priori for
age, race (Black/non-Hispanic or white/non-Hispanic), highest level of education completed
(less than high school, some college, completion of college or graduate school), income
(divided into $20,000 increments), employment status (unemployed, student, part-time, fulltime, disabled), body mass index (BMI), cigarette use (yes/no), baseline depression
(measured on Center for Epidemiologic Depression (CES-D) scale), partner status (married,
serious relationship and cohabitating, serious relationship and not cohabitating, no serious
relationship), extent of damage to vehicle (none/minor, moderate, severe), seatbelt use (yes/
no), speed of MVC, passenger vs. driver, moderate to severe axial pain, number of somatic
symptoms, and peritraumatic distress. Variables were operationalized as above; speed of
MVC was treated as a continuous variable. A similar multivariate logistic regression was
then performed with receipt of benzodiazepines as the outcome, adjusting for the same
factors. Race-by-gender interaction terms were tested in each model and kept based on
significance determined in likelihood ratio testing. For all logistic regression models,
adjusted odds ratios (OR) with 95% CI were reported. In all analyses, p-values < 0.05 were
considered statistically significant. All statistical analyses were performed using Stata
software v.14.0 (Stata Corporation, College Station, TX.)
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RESULTS
In total, 1878 patients were included; 61.4% (n=1153) were women, 49.5% (n=930) were
black, and overall median age was 32 (IQR 24–46). Table 1 describes demographic
characteristics and collision characteristics by gender. Women and men were similar in
terms of age and race yet differed with regard to factors including completed education,
income, partner status, and cigarette use. In terms of collision characteristics, more women
than men reported seatbelt use (91.8% vs. 84.0%), but women and men were similar with
respect to the extent of vehicle damage and whether they were the driver or passenger.

Author Manuscript

Table 2 shows pain experiences in women compared with men. Overall, women and men
were similar with respect to report of widespread pain, moderate to severe axial pain, and
attitudes regarding likelihood of recovery. In contrast, women reported more somatic
symptoms (3.9 vs. 3.3, p<0.001), and more women than men reported peritraumatic distress
(59.7% vs. 42.5%, p,0.001) and “severe” symptoms on the pain catastrophizing scale (55.2%
v. 27.5%, p=0.011).
Following stratification by race cohort (EA and AA) (Table 3), pain experience differed
between women and men in the EA cohort but not in the AA cohort. Compared to EA men,
EA women had more widespread pain, more moderate to severe axial pain, more somatic
symptoms, more severe pain on the pain catastrophizing scale, and more peritraumatic
distress. In the AA cohort, compared to men, women had more peritraumatic distress; all
other pain experiences were similar by gender.

Author Manuscript

With respect to treatment of pain at ED discharge, in unadjusted analyses, similar
proportions of women and men received a prescription for opioids (29.2% vs. 29.7%,
p=0.84) (Table 2). Similar numbers of women and men also received benzodiazepines (9.3%
vs. 11.6%, p=0.11) at time of discharge. Table 2 also shows that similar numbers of women
vs. men were given opioids or benzodiazepines during their ED stay. In the sample stratified
by cohort (EA and AA), there were no gender differences in the receipt of either opioid or
benzodiazepine prescriptions in either cohort (Table 3). There was, however, a difference in
receipt of opioids during the ED stay in the AA cohort but not the EA cohort (Table 3) in
unadjusted analyses.

Author Manuscript

Table S1 displays the results of our multivariate analysis of receipt of an opioid prescription
at discharge. After adjusting for demographic factors, collision characteristics, pain
(moderate to severe axial pain), somatic symptoms, peritraumatic distress, and depression,
women and men were equally likely to receive a prescription for opioids at the time of
discharge (RR 0.83, 95%CI 0.58–1.19). Increasing age (RR 1.01, 95%CI 1.00–1.02) and
moderate to severe axial pain (RR 1.95, 95%CI 1.40–2.75) increased the likelihood of
receiving an opioid prescription, while black race (RR 0.19, 95%CI 0.07–0.50) and seatbelt
use (RR 0.59, 95%CI 0.39–0.92) decreased the likelihood of receiving an opioid
prescription. Table S2 shows the results of our multivariate analysis of receipt of a
benzodiazepine prescription at discharge. After adjustment, women were less likely than
men to receive benzodiazepines at discharge (RR 0.53, 95%CI 0.32–0.88). Other significant
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predictors included BMI, partner status, and moderate to severe axial pain. Race-by-gender
interaction terms were not significant in either of these logistic regression models.

DISCUSSION

Author Manuscript

In our analysis of patients with minor injuries seen in the ED after a MVC, pain experiences
differed between women and men, specifically with respect to their acute psychological
responses. More women reported psychological distress, depression, somatic symptoms, and
pain catastrophizing compared with men. Though there were no differences in pain severity
between women and men in the overall sample, white/Non-Hispanic women had more
severe pain compared with white/Non-Hispanic men; no such gender difference existed in
the Black/Non-Hispanic cohort; this suggests that there may in fact be differences in pain
severity after MVC by gender, but that it differs by race. Despite gender differences in the
experience of pain and the acute psychological response, women and men were equally
likely to receive opioid pain medications at discharge after adjusting for pain, pain-related
distress, various demographic factors, social determinants, and collision characteristics. It is
possible that there were unmeasured differences between the EA and AA cohort and that the
association between gender and receipt of pain medications at discharge differs across racial
strata, though our preliminary analyses do not largely support this. Finally, women, however,
were less likely to receive a prescription for benzodiazepines, a somewhat surprising finding
given previous literature that women are more likely to be prescribed anxiolytics in both
outpatient and ED settings.21, 29

Author Manuscript
Author Manuscript

Our finding that women were more likely to report psychological sequelae after a MVC is
consistent with prior data showing that women and men differ with respect to their acute
psychological responses to pain.6, 10 Acute psychological responses to pain have the
potential to cause more severe acute pain and may lead to an increased risk of persistent
and/or chronic pain,30, 31 which is known to be more common in women than men.32, 33 It is
critical for physicians to recognize and address such acute psychological responses during
the ED visit by treating pain, providing reassurance, and factoring in psychosocial issues
that may affect a patient’s ability to cope with pain and distress following a MVC.
Furthermore, some data have indicated that gender may affect the response to pharmacologic
and non-pharmacologic interventions for pain,34, 35 but this needs to be investigated further,
especially with respect to reduction of post-traumatic distress and pain catastrophizing. Our
findings, while showing no significant gender difference in use of prescription opioids upon
ED discharge after MVC, suggest the need for future research investigating both reasons for
more pain-related psychological distress in women as well as possible gender-specific
interventions to prevent the development of psychological distress following MVCs. Future
research should also evaluate long-term outcomes in women vs. men after MVC and how
initial treatment in the ED may impact those outcomes and perhaps differentially with
respect to men and women.
Despite more distress exhibited by women compared with men after MVCs, women in our
study were less likely to receive benzodiazepines at discharge. It is plausible that
benzodiazepines in this setting would likely be prescribed because of their muscle relaxant
properties rather than their sedative or anxiolytic actions.18 Our findings may differ from
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previous studies that show higher rates of benzodiazepine use in women across a wide range
of clinical indications21 because our sample was limited to patients being seen for posttraumatic pain. Physicians may be less likely to use benzodiazepines for women with posttraumatic pain and distress if they believe the symptoms are time-limited, if the posttraumatic distress and anxiety is not recognized, or if they believe alternative interventions
would be more effective. These hypotheses would have to be tested in future research.

Author Manuscript

Our findings also conflict to some degree with prior literature indicating that women are at
risk for oligoanalgesia when being seen in the ED for pain-related conditions. For example,
one study of almost 1000 patients with non-traumatic abdominal pain in the ED reported
that even after adjusting for age, race, triage designation, and pain score, women were 13 to
25% less likely to receive opioid analgesia and had longer delays to administration of any
pain medication.15 Our findings that women and men were equally likely to receive opioids
may reflect differences in treatment of pain due to other pain complaints versus posttraumatic musculoskeletal pain or perhaps practice differences in the enrolling sites.

Author Manuscript

Finally, though not the primary objective of this paper, we found that Black patients were
less likely to receive opioid prescriptions. This is notable in light of data from a companion
project on race and post-traumatic pain using CRASH data showing that participants in the
AA cohort are over twice as likely to experience moderate to severe axial pain at 6 weeks
post MVC and are also more likely to have more severe pain in the ED.36 Other notable
differences by gender in our study include differences in demographics and crash
characteristics. For example, women were less likely to report seatbelt use, a factor which
deceased the likelihood of opioid prescriptions at discharge. Our findings of gender
differences in seatbelt use is consistent with prior data and could point to the need for
gender-specific education efforts to promote seatbelt use.37

Author Manuscript

There are some limitations to our study. First, it is possible that the two cohorts had
differences that affected our findings. For example, the two cohort studies (EA and AA)
were conducted during different study periods (2009–2011 and 2012–2016); it is possible
that the results would have differed if the cohorts were conducted simultaneously. In our
study, Black race was associated with lower rates of opioid prescriptions; given that opioid
prescription rates have risen in recent years It is possible that any difference by race was
underestimated. We only accounted for opioid and/or benzodiazepine prescriptions written
at the initial ED visit following the MVC, yet it is possible that some patients received
prescriptions from other physicians or in other healthcare settings after the initial ED visit.
We also did not have access to data on provider gender, which has been shown in some
studies to have even more effect than patient gender on the treatment of pain in the ED.38
Additional limitations include a potential lack of generalizability of our results to other
geographic regions (i.e., the western U.S.) and possible selection bias due to lack of
inclusion of non-English speaking patients. Finally, we did not have data on number of pain
or benzodiazepine pills prescribed, which could potentially be different between women and
men.
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CONCLUSIONS
In our large, multicenter study of ED patients treated for minor MVC, there were gender
differences in the acute psychological response to MVC with women reporting more
psychological and somatic symptoms. Women and men were equally likely to receive opioid
prescriptions at discharge in the overall sample even after adjusting for confounding factors.
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Table 1

Author Manuscript

Demographic and collision characteristics by gender
Women (n=1153)

Men (n=725)

Difference (95%CI)

34.9 (34.2 – 35.7)

36.0 (35.1 – 37.0)

1.1 (−0.1 – 2.3)

50.1 (578)

48.6 (352)

−1.6 (−6.2 – 3.1)

<$20,000

25.0 (243)

21.2 (127)

−3.8 (−8.1 – 0.4)

$20,000 to $40,000

28.2 (274)

20.7 (124)

−7.5 (−11.8 – −3.2)

$40,000 to $80,000

29.1 (283)

31.3 (188)

2.2 (−2.5 – 6.9)

>$80,000

17.7 (172)

26.8 (161)

9.1 (4.9 – 13.4)

High school or less

26.0 (299)

41.3 (297)

15.2 (10.8 – 19.6)

Some college

40.3 (463)

39.7 (286)

−0.6 (−5.1 – 4.0)

College/post-graduate level

33.7 (387)

19.0 (137)

−14.7 (−18.6 – −10.7)

Married

26.9 (310)

36.1 (261)

9.2 (4.9 – 13.5)

Serious relationship, not living together

17.4 (200)

14.7 (106)

−2.7 (−6.1 – 0.7)

Serious relationship, living together

15.0 (173)

12.7 (92)

−2.3 (−5.5 – 0.9)

No serious relationship

39.7 (457)

35.4 (256)

−4.3 (−8.7 – 0.2)

15.6 (148)

14.6 (89)

−1.0 (−4.6 – 2.7)

1.1 (10)

0.5 (3)

−0.6 (0.4 – 1.7)

Patient Demographics
Age
Race (% black)
Income

Education complete

Author Manuscript

Partner status

Employment status+
Unemployed
Student
Work part time

17.4 (165)

12.6 (77)

−4.7 (−8.3 – 1.2)

Work full time

64.9 (617)

71.6 (437)

6.8 (2.1 – 11.5)

Author Manuscript

Disabled

1.2 (11)

0.7 (4)

−0.5 (−1.4 – 0.4)

Cigarette use

23.2 (267)

31.9 (231)

8.7 (4.5 – 12.9)

None/minor

28.5 (317)

29.3 (204)

0.8 (−3.5 – 5.1)

Moderate

43.8 (487)

43.6 (304)

−0.2 (−4.9 – 4.5)

Severe

27.7 (308)

27.1 (189)

−0.6 (−4.8 – 3.6)

Seatbelt

91.8 (1052)

84.0 (584)

−7.8 (−10.9 – −4.6)

Passenger vs driver

78.8 (909)

76.9 (552)

−2.0 (−5.8 – 1.9)

Extent damage

Author Manuscript
Clin Ther. Author manuscript; available in PMC 2019 February 01.

Madsen et al.

Page 13

Table 2

Author Manuscript

Experience and treatment of pain after motor vehicle collision by gender
Women

Men

P-value

Widespread Pain

24.2 (21.7 – 26.7)

21.2 (18.3 – 24.2)

0.139

Moderate to severe axial pain

76.0 (73.5 – 78.4)

72.6 (69.3 – 75.8)

0.097

Number of somatic symptoms

3.9 (3.7 – 4.0)

3.3 (3.1 – 3.5)

<0.001

2.0 (1.4 – 3.0)

3.0 (2.0 – 4.5)

Pain experience

Pain catastrophizing scale

0.011

None
Mild

9.4 (7.8 – 11.1)

11.7 (9.5 – 14.3)

Moderate

33.5 (30.8 – 36.3)

37.8 (34.3 – 41.5)

Severe

55.2 (52.2 – 58.0)

47.5 (43.8 – 51.2)

Ces-D depression

Author Manuscript

Yes

8.7 (7.0 – 10.3)

3.9 (2.5 – 5.3)

<0.001

No

91.3 (89.6 – 92.8)

96.1 (94.5 – 97.3)

<0.001

Peritraumatic distress (>20)

59.7 (56.8 – 62.5)

42.5 (38.9 – 46.2)

<0.001

Likelihood of recovery

89.0 (87.2 – 90.9)

89.7 (87.4 – 91.9)

0.678

Proportion given opioids in the ED

20.6 (18.3 – 23.0)

17.8 (15.0 – 20.6)

0.130

Proportion given Benzos in the ED

6.4 (5.0 – 7.8)

6.3 (4.6 – 8.1)

0.950

29.2 (26.6 – 31.9)

29.7 (26.3 – 33.0)

0.843

9.3 (7.6 – 11.0)

11.6 (9.3 – 13.9)

0.108

Treatment
During ED visit

At discharge
Proportion given opioids discharge
Proportion given benzodiazepines at discharge

Author Manuscript

Continuous data are presented as median (interquartile range (IQR). Categorical data are displayed as proportions (%) and 95% confidence
intervals unless otherwise specified. P<0.05 was considered statistically significant.

Author Manuscript
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462 (79.9)
3.7 (2.8)

Moderate to severe axial pain

Number of somatic symptoms

478 (85.2)

Likelihood of recovery

35 (6.1)

Proportion given Benzodiazepines in the ED

Clin Ther. Author manuscript; available in PMC 2019 February 01.
37 (6.4)

Proportion given benzodiazepines at discharge

32 (9.1)

75 (21.3)

15 (4.3)

46 (13.1)

290 (84.8)

172(49.6)

6 (1.7)

397 (63.7)

103 (30.1)

19 (5.6)

2 (5.8)

3.4 (2.9)

280 (79.5)

98 (27.8)

Men

0.129

0.468

0.239

<0.001

0.867

<0.001

0.053

0.297

0.067

0.887

0.817

p-value

70 (12.2)

202 (35.1)

39 (6.8)

110 (19.1)

529 (92.8)

302(53.5)

77 (13.3)

228 (40.5)

234 (41.6)

82 (14.6)

19 (3.4)

4.1 (4.1)

414 (72.0)

114 (19.8)

Women

52 (13.9)

140 (37.5)

31 (8.3)

83 (22.2)

351 (94.1)

133(35.9)

22 (5.9)

116 (32.1)

163 (45.2)

63 (17.5)

19 (5.3)

3.3 (2.7)

246 (66.0)

56 (15.0)

Men

EA (n=948)

0.427

0.452

0.379

0.244

0.436

<0.001

<0.001

0.049

<0.001

0.048

0.059

Continuous data are presented as median (interquartile range (IQR). Categorical data are displayed as frequencies (n) and proportions (%)unless otherwise specified. P<0.05 was considered statistically
significant.

AA: African-American, EA: European-American

135 (23.4)

Proportion given opioids discharge

At discharge

128 (22.1)

Proportion given opioids in the ED

During ED visit

Treatment

23 (4.0)

Severe

376 (65.7)

218 (69.6)

Moderate

Peritraumatic distress

103 (25.4)

Mild

Depression (per CES-D)

2 (7.0)
19 (4.2)

None

Pain catastrophizing scale

165 (28.5)

Widespread Pain

Pain experience

Women

AA (n=930)
p-value

Author Manuscript

Pain Experience and Treatment of Pain in Sample Stratified by Race and Gender

Author Manuscript
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